Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,980 | 40,302 | 48,544 | 0 | N/A |
| Marketable Securities | 49,211 | 48,206 | 245 | 0 | N/A |
| Receivables | 5,054 | 675 | N/A | 0 | N/A |
| Inventories | 7,152 | 1,152 | N/A | 0 | N/A |
| Other current assets | 0 | 144 | 144 | 0 | 0 |
| TOTAL | $97,161 | $91,462 | $49,399 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,554 | 1,421 | 1,310 | 0 | N/A |
| Investments And Advances | 8,756 | 0 | 0 | 0 | 0 |
| Intangibles | 1,158 | 683 | 912 | 0 | 0 |
| Other Non-Current Assets | 1,366 | 423 | 2,109 | 0 | 0 |
| TOTAL | $13,834 | $2,527 | $4,331 | $N/A | $N/A |
| Total Assets | $110,995 | $93,989 | $53,730 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,142 | 10,666 | 11,763 | 0 | 0 |
| Accrued Expenses | 15,172 | N/A | N/A | 0 | N/A |
| TOTAL | $26,400 | $22,983 | $18,770 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 11,088 | 22,711 | 0 | N/A |
| Deferred Revenues | 8,086 | 508 | 232 | N/A | N/A |
| aiOther Non-Current Liabilities | 49,714 | 2,039 | 2,341 | 0 | 0 |
| TOTAL | $51,131 | $13,436 | $25,517 | $N/A | $N/A |
| Total Liabilities | $77,531 | $36,419 | $44,287 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,044 | 30,892 | N/A | N/A | N/A |
| Common Shares | 40 | 31 | 2 | 0 | N/A |
| Retained earnings | -178,528 | -86,255 | -39,971 | 0 | N/A |
| Other shareholders' equity | 0 | -57 | 50 | 0 | 0 |
| TOTAL | $33,464 | $57,570 | $9,443 | $0 | $N/A |
| Total Liabilities And Equity | $110,995 | $93,989 | $53,730 | $0 | $0 |